Treatment with aripiprazole once-monthly injectable formulation is effective in improving symptoms and global functioning in schizophrenia with and without comorbid substance use – a post hoc analysis of the ReLiAM study

Peer Review reports

Original Submission
12 May 2022	Submitted	Original manuscript
27 Jun 2022	Reviewed	Reviewer Report
27 Jul 2022	Reviewed	Reviewer Report
1 Sep 2022	Author responded	Author comments - Howard Margolese
Resubmission - Version 2
1 Sep 2022	Submitted	Manuscript version 2
11 Nov 2022	Author responded	Author comments - Howard Margolese
Resubmission - Version 3
11 Nov 2022	Submitted	Manuscript version 3
Publishing
16 Nov 2022	Editorially accepted
8 Dec 2022	Article published	10.1186/s12888-022-04397-x

Back to article page